BioArctic B
BIOA-B.ST OMXS HealthcareKursutveckling (180 dagar)
Kursutveckling vs OMX30
Fundamentala nyckeltal
AI-analys
Kort sikt (3 månader)
54/100Baserat enbart på tekniska signaler.
Lång sikt (3 år)
52/100Baserat enbart på sentiment, inga fundamenta tillgängliga.
Fallback: teknisk=9, sentiment=0. AI-analys ej tillgänglig.
- AI-analys misslyckades
Senaste nyheter
Why BioArctic Is On Investors’ Radar Today BioArctic (OM:BIOA B) has been drawing attention after recent share performance and fresh financial figures, prompting investors to reassess how its central ...
BioArctic AB (BRCTF) reports a transformative year with significant financial growth, new project expansions, and successful global partnerships, despite challenges in European markets.
Why BioArctic is on investors’ radar today BioArctic (OM:BIOA B) has recently drawn attention without a clear single news catalyst, as investors focus on its central nervous system drug pipeline, coll...
Eisai and partner BioArctic recently reported at the CTAD 2025 conference that long-term data for Leqembi (lecanemab) suggest early, continued treatment can substantially delay progression from mild c...
BioArctic AB reported its third quarter 2025 results, highlighting SEK133.35 million in sales compared to SEK76.63 million a year earlier, alongside a net loss of SEK86.87 million due to increased R&D...